» Articles » PMID: 38066300

Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer

Abstract

Metastasis is the leading cause of cancer-related deaths of breast cancer patients. Some cancer cells in a tumour go through successive steps, referred to as the metastatic cascade, and give rise to metastases at a distant site. We know that the plasticity and heterogeneity of cancer cells play critical roles in metastasis but the precise underlying molecular mechanisms remain elusive. Here we aimed to identify molecular mechanisms of metastasis during colonization, one of the most important yet poorly understood steps of the cascade. We performed single-cell RNA-Seq (scRNA-Seq) on tumours and matched lung macrometastases of patient-derived xenografts of breast cancer. After correcting for confounding factors such as the cell cycle and the percentage of detected genes (PDG), we identified cells in three states in both tumours and metastases. Gene-set enrichment analysis revealed biological processes specific to proliferation and invasion in two states. Our findings suggest that these states are a balance between epithelial-to-mesenchymal (EMT) and mesenchymal-to-epithelial transitions (MET) traits that results in so-called partial EMT phenotypes. Analysis of the top differentially expressed genes (DEGs) between these cell states revealed a common set of partial EMT transcription factors (TFs) controlling gene expression, including ZNF750, OVOL2, TP63, TFAP2C and HEY2. Our data suggest that the TFs related to EMT delineate different cell states in tumours and metastases. The results highlight the marked interpatient heterogeneity of breast cancer but identify common features of single cells from five models of metastatic breast cancer.

Citing Articles

Mechanistic elucidation of human pancreatic acinar development using single-cell transcriptome analysis on a human iPSC differentiation model.

Mima A, Kimura A, Ito R, Hatano Y, Tsujimoto H, Mae S Sci Rep. 2025; 15(1):4668.

PMID: 39920294 PMC: 11806057. DOI: 10.1038/s41598-025-88690-1.


Subtype-specific role for Jagged1 in promoting or inhibiting breast tumor formation.

Chung W, Wang W, Challagundla L, Moore C, Egan S, Xu K Oncogenesis. 2025; 14(1):2.

PMID: 39890784 PMC: 11785972. DOI: 10.1038/s41389-025-00545-6.


Metabolic shifts in lipid utilization and reciprocal interactions within the lung metastatic niche of triple-negative breast cancer revealed by spatial multi-omics.

Kan J, Lee H, Hou M, Tsai H, Jian S, Chang C Cell Death Dis. 2024; 15(12):899.

PMID: 39695088 PMC: 11655832. DOI: 10.1038/s41419-024-07205-4.


Deciphering gene expression patterns using large-scale transcriptomic data and its applications.

Chen S, Wang P, Guo H, Zhang Y Brief Bioinform. 2024; 25(6).

PMID: 39541191 PMC: 11562847. DOI: 10.1093/bib/bbae590.

References
1.
Jehanno C, Vulin M, Richina V, Richina F, Bentires-Alj M . Phenotypic plasticity during metastatic colonization. Trends Cell Biol. 2022; 32(10):854-867. DOI: 10.1016/j.tcb.2022.03.007. View

2.
Jiramongkol Y, Lam E . FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev. 2020; 39(3):681-709. PMC: 7497309. DOI: 10.1007/s10555-020-09883-w. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Saitoh M . Involvement of partial EMT in cancer progression. J Biochem. 2018; 164(4):257-264. DOI: 10.1093/jb/mvy047. View

5.
Gao H, Korn J, Ferretti S, Monahan J, Wang Y, Singh M . High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med. 2015; 21(11):1318-25. DOI: 10.1038/nm.3954. View